These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1331574)

  • 1. [Fundamental studies of hepatitis C virus: a review].
    Fujiyama S; Kawano S
    Rinsho Byori; 1992 Sep; 40(9):911-7. PubMed ID: 1331574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
    Hige S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.
    Tsutsumi M; Urashima S; Takada A; Date T; Tanaka Y
    Hepatology; 1994 Feb; 19(2):265-72. PubMed ID: 7507461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of N-14 antibody (ELISA) in diagnosis of non-A, non-B liver disease].
    Yone Y
    Fukuoka Igaku Zasshi; 1992 Apr; 83(4):156-67. PubMed ID: 1318860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Summary and evaluation of genome and antibody diagnosis in hepatitis C virus infection].
    Nishizono A
    Rinsho Byori; 1994 Dec; 42(12):1240-7. PubMed ID: 7532727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis C.
    Sherlock DS
    Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.
    Barrera JM; Bruguera M; Ercilla MG; Gil C; Celis R; Gil MP; del Valle Onorato M; Rodés J; Ordinas A
    Hepatology; 1995 Mar; 21(3):639-44. PubMed ID: 7533121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hepatitis C virus--principal causative agent in non-A, non-B hepatitis].
    Schaff Z; Lapis K
    Orv Hetil; 1990 Sep; 131(35):1903-6. PubMed ID: 2170894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-A, non-B hepatitis: hepatitis C].
    de Moura MC
    Acta Med Port; 1990; 3(4):209-12. PubMed ID: 2177314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
    Paterlini P; Driss F; Nalpas B; Pisi E; Franco D; Berthelot P; Bréchot C
    Hepatology; 1993 Jan; 17(1):20-9. PubMed ID: 8380790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.